1. Home
  2. OCS vs AACT Comparison

OCS vs AACT Comparison

Compare OCS & AACT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCS
  • AACT
  • Stock Information
  • Founded
  • OCS 2003
  • AACT 2021
  • Country
  • OCS Switzerland
  • AACT United States
  • Employees
  • OCS N/A
  • AACT N/A
  • Industry
  • OCS Biotechnology: Pharmaceutical Preparations
  • AACT
  • Sector
  • OCS Health Care
  • AACT
  • Exchange
  • OCS Nasdaq
  • AACT Nasdaq
  • Market Cap
  • OCS 689.8M
  • AACT 697.5M
  • IPO Year
  • OCS N/A
  • AACT 2023
  • Fundamental
  • Price
  • OCS $18.58
  • AACT $11.28
  • Analyst Decision
  • OCS Strong Buy
  • AACT
  • Analyst Count
  • OCS 4
  • AACT 0
  • Target Price
  • OCS $31.50
  • AACT N/A
  • AVG Volume (30 Days)
  • OCS 30.4K
  • AACT 1.2M
  • Earning Date
  • OCS 05-08-2025
  • AACT 01-01-0001
  • Dividend Yield
  • OCS N/A
  • AACT N/A
  • EPS Growth
  • OCS N/A
  • AACT 15.24
  • EPS
  • OCS N/A
  • AACT 0.42
  • Revenue
  • OCS $847,333.00
  • AACT N/A
  • Revenue This Year
  • OCS $49.27
  • AACT N/A
  • Revenue Next Year
  • OCS $1,920.31
  • AACT N/A
  • P/E Ratio
  • OCS N/A
  • AACT $27.11
  • Revenue Growth
  • OCS N/A
  • AACT N/A
  • 52 Week Low
  • OCS $10.79
  • AACT $10.58
  • 52 Week High
  • OCS $23.08
  • AACT $11.29
  • Technical
  • Relative Strength Index (RSI)
  • OCS 54.68
  • AACT 61.90
  • Support Level
  • OCS $18.01
  • AACT $11.26
  • Resistance Level
  • OCS $19.50
  • AACT $11.29
  • Average True Range (ATR)
  • OCS 0.77
  • AACT 0.03
  • MACD
  • OCS 0.17
  • AACT 0.00
  • Stochastic Oscillator
  • OCS 66.30
  • AACT 82.35

About OCS Oculis Holding AG Ordinary shares

Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.

About AACT Ares Acquisition Corporation II

Ares Acquisition Corp II is a blank check company.

Share on Social Networks: